OPKO Health (OPK)
(Real Time Quote from BATS)
$1.56 USD
-0.07 (-4.29%)
Updated Dec 11, 2023 11:00 AM ET
3-Hold of 5 3
C Value B Growth F Momentum D VGM
Price, Consensus and EPS Surprise
OPK 1.56 -0.07(-4.29%)
Will OPK be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for OPK based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OPK
Here's Why You Should Retain OPKO Health (OPK) Stock for Now
Why Is OPKO Health (OPK) Up 18.7% Since Last Earnings Report?
OPK: What are Zacks experts saying now?
Zacks Private Portfolio Services
OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues Top
OPKO Health (OPK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
OPKO Health (OPK) Gets BARDA Contract to Combat Antibody Threats
Other News for OPK
What's Driving Twist Bioscience Corp's Surprising 14% Stock Rally?
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
What's Driving Twist Bioscience Corp's Surprising 29% Stock Rally?
What's Driving NeoGenomics Inc's Surprising 42% Stock Rally?
Twist Bioscience Corp's Stock Performance: A Detailed Analysis